DBV Technologies DBVT
NASDAQ DBVT
$11.88 +0.37 (+3.21%)
At close: Nov 11, 2026 · 4:00 PM EST

DBV Technologies (DBVT) Return on Capital Employed [ROCE] (2019 - 2026)

Updated

DBV Technologies (DBVT) recorded Return on Capital Employed [ROCE] of -129.57% in Q3 2026, up 32.87 percentage points from -162.45% a year earlier but down 36.21 percentage points from the prior quarter.

Analysis

DBV Technologies (DBVT) Return on Capital Employed [ROCE] (2019 - 2026) Analysis & Trends

For FY2025, DBV Technologies reported Return on Capital Employed [ROCE] of -160.40%, down 35.29 percentage points from FY2024.

  • Annual Return on Capital Employed [ROCE] has a five-year change of -87.96 percentage points (FY2020 to FY2025).
  • Across earlier years, Return on Capital Employed [ROCE] came in at -125.11% in FY2024 (-82.03 pp), -43.08% in FY2023 (+14.75 pp), -57.83% in FY2022 (-2.45 pp) and -55.37% in FY2021 (+17.07 pp).
  • Quarterly Return on Capital Employed [ROCE] has ranged from -646.68% in Q1 2025 to -30.27% in Q3 2022 over the past five years.
  • On a year-over-year basis, Return on Capital Employed [ROCE] has increased for four consecutive quarters, with an average year-over-year change of -11.32 percentage points over the last eight quarters.
  • Peak year-over-year performance for Return on Capital Employed [ROCE] in the last five years was a gain of 561.76 percentage points in Q1 2026, against a drop of 585.92 percentage points in Q1 2025 at the low end.
  • Per Business Quant, the preceding three quarters came in at -93.36% (Q2 2026), -84.92% (Q1 2026) and -128.89% (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 35.41%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 17.52%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 21.60%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 4.65%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.91%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 17.37%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -6.15%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 11.32%
10 DBV Technologies 1.04 Bn 274.26 Mn - -129.57%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -129.57%
Jun 30, 2026 -93.36%
Mar 31, 2026 -84.92%
Dec 31, 2025 -128.89%
Sep 30, 2025 -162.45%
Jun 30, 2025 -256.23%
Mar 31, 2025 -646.68%
Dec 31, 2024 -241.78%
Sep 30, 2024 -143.93%
Jun 30, 2024 -90.19%
Mar 31, 2024 -60.76%
Dec 31, 2023 -51.28%
Sep 30, 2023 -59.54%
Jun 30, 2023 -53.31%
Mar 31, 2023 -48.82%
Dec 31, 2022 -44.37%
Sep 30, 2022 -30.27%
Jun 30, 2022 -45.91%
Mar 31, 2022 -80.80%
Dec 31, 2021 -77.39%
API Access

DBV Technologies Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=DBVT&period=max&api_key=YOUR_API_KEY